Ulrich Müller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ulrich Müller has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
Dagmar Nolte
Institute of Human Genetics, Justus Liebig University, Giessen, Germany
5 shared publicationsDaniela Steinberger
Justus-Liebig Universität
5 shared publicationsThilo Herzfeld
Institute of Human Genetics, University of Giessen, Giessen, Germany
5 shared publications- Axel Weber
Institute of Human Genetics Justus‐Liebig‐University Giessen Germany
4 shared publications - Günter Ulrich Höglinger
Department of Neurology, LMU University Hospital, Ludwig-Maximilians- Universität (LMU) München, Munich, Germany
4 shared publications Stephan Niemann
Justus-Liebig-Universität
4 shared publications
Latest Publications
- Open Access
- 26 July 2018
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 2929
Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1
Genetic, epigenetic, and environmental factors contribute to the multifactorial disorder progressive supranuclear palsy (PSP). Here, we study epigenetic changes by genome-wide analysis of DNA from postmortem tissue of forebrains of patients and controls and detect significant (P < 0.05) methylation differences at 717 CpG sites in PSP vs. controls. Four-hundred fifty-one of these sites are associated with protein-coding genes. While differential methylation only affects a few sites in most genes,DLX1is hypermethylated at multiple sites. Expression of an antisense transcript ofDLX1,DLX1AS, is reduced in PSP brains. The amount of DLX1 protein is increased in gray matter of PSP forebrains. Pathway analysis suggests that DLX1 influencesMAPT-encoded Tau protein. In a cell system, overexpression ofDLX1results in downregulation ofMAPTwhile overexpression ofDLX1AScauses upregulation ofMAPT. Our observations suggest that alteredDLX1methylation and expression contribute to pathogenesis of PSP by influencingMAPT.
- 26 July 2018
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 2929
Open AccessEpigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1
Genetic, epigenetic, and environmental factors contribute to the multifactorial disorder progressive supranuclear palsy (PSP). Here, we study epigenetic changes by genome-wide analysis of DNA from postmortem tissue of forebrains of patients and controls and detect significant (P < 0.05) methylation differences at 717 CpG sites in PSP vs. controls. Four-hundred fifty-one of these sites are associated with protein-coding genes. While differential methylation only affects a few sites in most genes,DLX1is hypermethylated at multiple sites. Expression of an antisense transcript ofDLX1,DLX1AS, is reduced in PSP brains. The amount of DLX1 protein is increased in gray matter of PSP forebrains. Pathway analysis suggests that DLX1 influencesMAPT-encoded Tau protein. In a cell system, overexpression ofDLX1results in downregulation ofMAPTwhile overexpression ofDLX1AScauses upregulation ofMAPT. Our observations suggest that alteredDLX1methylation and expression contribute to pathogenesis of PSP by influencingMAPT.
- Open Access
- 28 November 2017
- Published by International Union of Crystallography (IUCr) in Acta crystallographica Section B, Structural science, crystal engineering and materials
- Vol. 73 (6) , 1198-1199
Crystal Chemistry. From Basics to Tools for Materials Creation. By Gérard Ferey. World Scientific, 2017, 264 pp. Softcover ISBN 978-981-3144-19-4, price GBP 46.00, hardback, ISBN 978-981-3144-18-7, price GBP 81.00
- 28 November 2017
- Published by International Union of Crystallography (IUCr) in Acta crystallographica Section B, Structural science, crystal engineering and materials
- Vol. 73 (6) , 1198-1199
Open AccessCrystal Chemistry. From Basics to Tools for Materials Creation. By Gérard Ferey. World Scientific, 2017, 264 pp. Softcover ISBN 978-981-3144-19-4, price GBP 46.00, hardback, ISBN 978-981-3144-18-7, price GBP 81.00
- 21 November 2017
- Published by Springer Nature in neurogenetics
- Vol. 18 (4) , 183-184
Developing the field of neurogenetics
- 21 November 2017
- Published by Springer Nature in neurogenetics
- Vol. 18 (4) , 183-184
Developing the field of neurogenetics
- 6 July 2017
- Published by Taylor & Francis
- p. 1-12
Integrating Philosophy, Theory, and Method in Contemporary Developmental Science
The motivation for this volume grew out of discussions to honor the life’s work of Professor Willis “Bill” Overton, whose writings on the conceptual foundation of developmental science have shaped the field for decades and encouraged developmental researchers to think about the broad assumptions that guide their own empirical and theoretical work. As such, this volume is simultaneously an introduction to and overview of the field of developmental science for students and scientists, a detailed review of a number of topics in developmental science framed in the context of Overton’s theoretical and metatheoretical writings, and a festschrift honoring Overton’s immense contributions to developmental science over the course of his career.
- 6 July 2017
- Published by Taylor & Francis
- p. 1-12
Integrating Philosophy, Theory, and Method in Contemporary Developmental Science
The motivation for this volume grew out of discussions to honor the life’s work of Professor Willis “Bill” Overton, whose writings on the conceptual foundation of developmental science have shaped the field for decades and encouraged developmental researchers to think about the broad assumptions that guide their own empirical and theoretical work. As such, this volume is simultaneously an introduction to and overview of the field of developmental science for students and scientists, a detailed review of a number of topics in developmental science framed in the context of Overton’s theoretical and metatheoretical writings, and a festschrift honoring Overton’s immense contributions to developmental science over the course of his career.
- 1 December 2016
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 33, 115-121
Parkinson's disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus
- 1 December 2016
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 33, 115-121
Parkinson's disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus
- 6 April 2016
- Published by Springer Nature in neurogenetics
- Vol. 17 (3) , 165-171
microRNA profiling: increased expression of miR-147a and miR-518e in progressive supranuclear palsy (PSP)
Progressive supranuclear palsy is a sporadic neurodegenerative disorder. Genetic, environmental, and possibly epigenetic factors contribute to disease. In order to better understand the potential role of epigenetic changes in progressive supranuclear palsy, we investigated whether some microRNAs and their target genes are dysregulated. We analyzed expression of 372 well-characterized microRNAs in forebrains of a total of 40 patients and of 40 controls using TaqMan arrays and SYBR Green quantitative real-time PCR. The exploratory cohort included forebrains from 20 patients and 20 controls provided by the Erasmus Medical Centre in Rotterdam, Netherlands. Confirmatory samples were from Jacksonville, Florida, and from Melbourne, Australia. Both microRNA profiling and SYBR Green quantitative real-time PCR revealed significant upregulation of miR-147 (miR-147a) and miR-518e in the exploratory cohort. Highly increased expression of these two microRNAs was validated in the confirmatory samples. Target genes of miR-147a (NF1, ACLY, ALG12) and of miR-518e (CPEB1, JAZF1, RAP1B) were repressed in patients’ forebrains. The results suggest that dysregulation of specific microRNAs contributes to disease by repressing target genes involved in various cellular functions.
- 6 April 2016
- Published by Springer Nature in neurogenetics
- Vol. 17 (3) , 165-171
microRNA profiling: increased expression of miR-147a and miR-518e in progressive supranuclear palsy (PSP)
Progressive supranuclear palsy is a sporadic neurodegenerative disorder. Genetic, environmental, and possibly epigenetic factors contribute to disease. In order to better understand the potential role of epigenetic changes in progressive supranuclear palsy, we investigated whether some microRNAs and their target genes are dysregulated. We analyzed expression of 372 well-characterized microRNAs in forebrains of a total of 40 patients and of 40 controls using TaqMan arrays and SYBR Green quantitative real-time PCR. The exploratory cohort included forebrains from 20 patients and 20 controls provided by the Erasmus Medical Centre in Rotterdam, Netherlands. Confirmatory samples were from Jacksonville, Florida, and from Melbourne, Australia. Both microRNA profiling and SYBR Green quantitative real-time PCR revealed significant upregulation of miR-147 (miR-147a) and miR-518e in the exploratory cohort. Highly increased expression of these two microRNAs was validated in the confirmatory samples. Target genes of miR-147a (NF1, ACLY, ALG12) and of miR-518e (CPEB1, JAZF1, RAP1B) were repressed in patients’ forebrains. The results suggest that dysregulation of specific microRNAs contributes to disease by repressing target genes involved in various cellular functions.
- Open Access
- 3 March 2016
- Published by Springer Nature in BMC Medical Genetics
- Vol. 17 (1) , 1-3
Intronic PRRT2 mutation generates novel splice acceptor site and causes paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC) in a three generation family
- 3 March 2016
- Published by Springer Nature in BMC Medical Genetics
- Vol. 17 (1) , 1-3
Open AccessIntronic PRRT2 mutation generates novel splice acceptor site and causes paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC) in a three generation family
- Open Access
- 9 December 2014
- Published by Springer Nature in Molecular Cytogenetics
- Vol. 7 (1) , 94
8p23.1 duplication syndrome: narrowing of critical interval to 1.80 Mbp
A 3.68 Mbp duplication of 8p23.1 defines the 8p23.1 duplication syndrome. The main features of this syndrome are developmental delay and/or learning problems. Here we present a patient with a 1.80 Mbp duplication in 8p23.1 and characteristic signs and symptoms of the syndrome, including delay of motor and speech development and intellectual disability. The case indicates that genes within this interval, in particular dosage sensitive genes SOX7 and TNKS1, and possibly MIR124-1 and MIR598 as well suffice to cause the pathognomonic features of the 8p23.1 duplication syndrome.
- 9 December 2014
- Published by Springer Nature in Molecular Cytogenetics
- Vol. 7 (1) , 94
Open Access8p23.1 duplication syndrome: narrowing of critical interval to 1.80 Mbp
A 3.68 Mbp duplication of 8p23.1 defines the 8p23.1 duplication syndrome. The main features of this syndrome are developmental delay and/or learning problems. Here we present a patient with a 1.80 Mbp duplication in 8p23.1 and characteristic signs and symptoms of the syndrome, including delay of motor and speech development and intellectual disability. The case indicates that genes within this interval, in particular dosage sensitive genes SOX7 and TNKS1, and possibly MIR124-1 and MIR598 as well suffice to cause the pathognomonic features of the 8p23.1 duplication syndrome.
- 11 August 2014
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 42 (1) , 109-113
Previously Unrecognized Missense Mutation E126K of PSEN2 Segregates with Early Onset Alzheimer's Disease in a Family
Mutations in the gene PSEN2 are a rare cause of early onset Alzheimer's disease (EOAD). PSEN2 sequence variants are often only found in one patient and pathogenicity cannot be formally documented. Here we describe a previously unrecognized sequence c
- 11 August 2014
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 42 (1) , 109-113
Previously Unrecognized Missense Mutation E126K of PSEN2 Segregates with Early Onset Alzheimer's Disease in a Family
Mutations in the gene PSEN2 are a rare cause of early onset Alzheimer's disease (EOAD). PSEN2 sequence variants are often only found in one patient and pathogenicity cannot be formally documented. Here we describe a previously unrecognized sequence c
- 30 July 2014
- Published by Springer Nature in DNP - Der Neurologe und Psychiater
- Vol. 15 (7-8) , 3-4
Rasante Entwicklung der Gendiagnostik
- 30 July 2014
- Published by Springer Nature in DNP - Der Neurologe und Psychiater
- Vol. 15 (7-8) , 3-4
Rasante Entwicklung der Gendiagnostik